Executive Team

Paul Edalat

Chairman of the Board, Interim CEO, CBDO

With more than 30 years of brand and product development experience in the nutraceutical, pharmaceutical, and medical device sectors, Mr. Edalat brings a keen eye for business development and growth opportunities to Vivera. His forward-thinking management approach as interim CEO has seen Vivera grow from a single division at its founding to over seven divisions and counting today.

Leading Vivera’s business development domestically and internationally, Mr. Edalat works closely with Vivera’s sales and marketing teams to anticipate and meet market demands. With trusted global relationships built over the decades, Mr. Edalat has worked to leverage his connections and expand Vivera’s reach. At home, he has led the Company through innovative research and development, focusing on maintaining Vivera’s core mission – putting patients first.

Gregory P. Hannley

Chief Recovery Officer, Board of Directors

As both a successful entrepreneur and investor, Mr. Hannley has spent his career helping those who need it most. As the founder of the Soba Recovery Centers, Mr. Hannley is aware of how critical high quality and competent in-patient services are for addiction treatment. His model takes a full-service holistic approach to not only treat drug and alcohol addiction, but to address the underlying causes. He is a passionate advocate for addiction treatment and alternative therapies to assist in the recovery of those afflicted.

Mr. Hannley has appeared on Larry King Live and 20/20.

R.J. Demman

Chief Operations Officer

With over 20 years of comprehensive operations and business development experience, Mr. Demman has spent his career building and maintaining relationships across the board. He is well-versed in the needs of high-volume, high-profile companies. His expertise in crafting programs aimed at increasing revenue and growth while maintaining strong relationships with government, regulators, and stakeholders makes Mr. Demman the ideal candidate to oversee the day-to-day operations of Vivera while working with the Executive team on long-term growth strategies.

Olivia Karpinski

Co-Founder and Director

Ms. Karpinski is the Vice President of Sales and Marketing for Vivera Pharmaceuticals. Passionate about public health, Olivia has been in the healthcare industry for over 10 years. Her multifaceted expertise in product knowledge and business development helps her lead the sales team for Vivera while always seeking new, synergistic opportunities for the Company. Ms. Karpinski was formerly a Senior Business Analyst in the Medical Special Investigations Unit at Fortune 100 Company, Liberty Mutual. She is Lean Six Sigma certified and certified by the National Insurance Crime Bureau in special investigations and major medical fraud.

Stephen J. McColgan, M.D. M.B.A.

Chief Medical Officer

Dr. McColgan was one of the first surgeons to perform Laparoscopic Cholecystectomy, Laparoscopic Nissen Fundoplication, and Laparoscopic Gastric bypass in the Southern California area. His multi-decade experience as not only a premier surgeon but as a successful entrepreneur bring a highly desirable mix of science and business to Vivera’s executive team. Before co-founding Endodynamix, Inc., Dr. McColgan spent 10 years as the Chairman for the Department of Surgery at Bellflower Medical Center in Southern California. Currently Dr. McColgan is a lecturer at University of California Riverside’s School of Medicine. As part of Vivera’s medical advisory team, Dr. McColgan works with the regulatory and scientific teams to develop protocols, novel products, and guide Vivera towards new horizons in healthcare.

Mehdi Hatamian, Ph.D.

Senior Scientific Advisor, Interim Chief Scientific Officer

As a former NASA Space Shuttle program engineer and a 20-year career at Broadcom as the Chief Scientist for Central Engineering, Dr. Hatamian brings an engineer’s mindset to Vivera. With over 100 issued patents, and the publisher of 50 scientific papers, he is a scientist at heart. Dr. Hatamian works closely with Vivera’s team to expand our Medical Technology and Medical Device divisions, bringing not only his engineering expertise but for his knowledge of medical research. Dr. Hatamian is the founder and CEO of 2Pi-Sigma, a biomedical firm working on next-generation cancer detection devices and technologies.

Charles S. Freeman

Director of Corporate Security

After 34 years in law enforcement, Mr. Freeman joined Vivera after retiring as a Police Sergeant. He is a highly-skilled investigator and experienced professional who works closely with the executive team to ensure both operational and digital security for the Company. For most of his career with the Newport Beach Police Department, Mr. Freeman oversaw the Special Investigations Unit, requiring him to maintain security clearance with the FBI. Mr. Freeman ensures the day-to-day physical security of the Company and works with the team to ensure that every aspect of Vivera’s operations is well secured.